Industry Experts

Jürgen Klattig is Director of Antibody Discovery & Protein Interactions at iOmx, where he advances innovative technologies for therapeutic antibody identification and characterization. In parallel, he works as a consultant for startups and life science organizations, advising on innovation strategies and project management. Before that, he was Site Head Discovery at ProBioGen AG and spent over 16 years at MorphoSys AG, most recently as Director Core Technologies, leading antibody discovery platforms and preclinical projects. Dr. Klattig studied Biology at the Technical University of Munich and conducted research at Epidauros Biotechnology AG, the University of Würzburg and the Leibniz Institute on Aging.